Manufacturing Scientist

  • 3,416 views
Uploaded on

A presentation on working as a manufacturing scientist in a company specialising in provision of clinical trials …

A presentation on working as a manufacturing scientist in a company specialising in provision of clinical trials
(c) Pharmaceutical Profiles and Steve Coney, 2009

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
3,416
On Slideshare
0
From Embeds
0
Number of Embeds
2

Actions

Shares
Downloads
9
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Bridging the Gap From Medical Biochemistry to Clinical Trials Steve Coney – Manufacturing Scientist Pharmaceutical Profiles Ltd 12 March 2009 03/12/09 Pharmaceutical Profiles 1
  • 2. Who are Pharmaceutical Profiles? • Nottingham University spin out – 1990, School of Pharmaceutical Sciences • Unique and differentiated technology • Approximately 100 people – 20,000 ft2 Ruddington, Nottingham • >30 clinical studies per year – Global customer base – 65% USA, 25% Europe, 10% Japan 03/12/09 Pharmaceutical Profiles
  • 3. How do we make our money? Clinical investigation of bioavailability issues • Application of novel technologies and methodologies to understand how to build an optimal drug formulation for man – EnterionTM, iv MicroTracer PK, pharmacoscintigraphy Rapid evaluation of new formulations in man • Integrated manufacturing and clinical evaluation to enable rapid evaluation and validation of test formulations – Oral, inhaled, intravenous, and intranasal routes of delivery 03/12/09 Pharmaceutical Profiles
  • 4. The Enterion Capsule 03/12/09 Pharmaceutical Profiles
  • 5. What do we do? Manufacturing Clinical GCP Facility, 30 beds GMP Facility Phase 0 microdosing Formulation R&D IV PK & Metabolism Analytical R&D Phase I Radiolabelling Phase IIa POC CT manufacture Pharmacoscintigraphy Remote controlled Formulation validation Targeted within GI Gastric emptying/motility Multiple dosage forms Lung / nasal deposition Imaging Enterion TM Enterion Imaging 03/12/09 Pharmaceutical Profiles
  • 6. Who do we work for? • Worked with the majority of top 30 pharma companies • Over 250 biotechnology companies • Greater than 30 marketed oral drugs • >50 oral drugs currently in development • 16 of the top 100 selling drugs 03/12/09 Pharmaceutical Profiles
  • 7. What can we do? •Radiolabelled egg Enterion capsules • Routes of administration •Radiolabelled drink Tablets • • Oral •Nasal sprays Capsules • Intravenous • • Inhaled •pMDIs • Intranasal Solutions • • Rectal •Powder inhalers • Intravaginal Aseptic manipulations • • Dermal •Nebulised doses Ointments & creams • •14C-microdoses Neutron Activation • •Encapsulation 03/12/09 Pharmaceutical Profiles
  • 8. Clinical Trials – an Overview • Four main stages: – Phase I Initial human testing - safety – Phase II Dose finalisation – Phase III Therapeutic trials – Phase IV Post-marketing safety monitoring • Also one further stage: – Phase 0 “microdosing” 03/12/09 Pharmaceutical Profiles
  • 9. Where does PP fit in? • Mainly Phases 0, I and II (although some III) • Market leader in Phase 0 IV 14C-microdosing 03/12/09 Pharmaceutical Profiles
  • 10. About Me • Graduated 2006 BSc(hons) Medical Biochemistry • June 2006-April 2007 UHL Nursing Auxilliary • Joined PP April 2007 • Married June 2007 03/12/09 Pharmaceutical Profiles
  • 11. What do I do? • Manufacturing Scientist • Prepare Investigational Medicinal Products (IMPs) • Manage supplies • Perform in vitro experiments • Trained to handle radioactive materials 03/12/09 Pharmaceutical Profiles
  • 12. How do you get into Clinical Trials? • Apply for jobs • Gain experience in the Pharmaceutical/Food Industry • Many roles requiring Bioscience graduates • Volunteer!! 03/12/09 Pharmaceutical Profiles
  • 13. Any Questions? 03/12/09 Pharmaceutical Profiles 13